Patent Yard Sign in
Expired European patentEurope

Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis

EP 1019078 B1 · Applicant: AstraZeneca AB

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed April 14, 1998 and granted July 23, 2003. A European patent lasts at most 20 years from filing, so its term ended April 14, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by October 14, 2023.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledApril 14, 1998
PublishedJuly 19, 2000
GrantedJuly 23, 2003
Term endedApril 14, 2018
Application numberEP 98917896
Classification (CPC)A61P29/00 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedApril 14, 1998PublishedJuly 19, 2000Patent grantedJuly 23, 2003Term endedApril 14, 2018

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.